News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Photo collage of Laura Bukavina and Phillip Abbosh
Jul 4, 2024, 13:06

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:

“The NTACT residual disease test, eloquently presented by Phillip Abbosh published in JCO Precision Oncology. Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT cancer. NTACT demonstrated 91% sensitivity and 82% accuracy.”

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Read further.
Source: Laura Bukavina/X

cancer cancer mutations Cleveland Clinic field cancerization JCO Precision Oncology Laura Bukavina NTACT OncoDaily Oncology oncology research Phillip Abbosh Precision Medicine residual disease test Urologic Oncologist
Special Coverage
Blog
Feb 21, 2025, 11:52
Zainab Shinkafi-Bagudu: Exploring collaborations in cancer care with the Indian High Commission in Abuja
Blog
Feb 21, 2025, 11:51
Integrative medicine for cancer-related pain and anxiety/depression - Society for Integrative Oncology
Insight
Feb 21, 2025, 11:40
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Science
Feb 21, 2025, 11:36
Myeloma Paper of the Day, February 21st, suggested by Robert Orlowski
Dialogues
Feb 21, 2025, 11:29
HPV Self-Collection for Cervical Cancer: Dr. Kay's Insights
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky
Celebrities
Feb 21, 2025, 10:28
In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer
Science
Feb 21, 2025, 10:07
Elai Davicioni: Predicting Dose-Response to Prostate Cancer Radiotherapy